Nasdaq 100 and S&P500: Tech Stocks Support US Indices While Markets Eye Fed Decision

U.S. equities traded mixed as investors positioned ahead of Wednesday’s Fed decision, with CME FedWatch pricing an 89.6% chance of a 25-basis-point cut and market focus on a potentially split FOMC. By 15:23 GMT the Dow was down 0.19%, the S&P 500 slipped 0.016% and the Nasdaq eased 0.03%; tech was the only S&P sector in the green (up ~0.48%) led by Broadcom (~+3%) and Oracle (+2.4%). Large corporate moves reshaped early action: Warner Bros Discovery jumped 7.2% after Paramount launched a $108.4bn hostile bid, Confluent surged 28.5% after IBM agreed to buy it for roughly $11bn, Marvell fell 8.2% after S&P rebalance exclusion, and Carvana rose 7.2% on S&P inclusion. Moderately stronger late-Q3 consumer spending reinforced expectations that the Fed will emphasize labor-market support, while Chair Powell’s press conference remains the key market catalyst.

Analysis

Market structure is bifurcating: tech and M&A beneficiaries (AVGO, MSFT, ORCL, WBD, IBM, CFLT) pick up near-term share as rates bias toward a 25bp cut (CME 89.6%); mechanically hit names include MRVL (S&P exclusion) and parts of media (NFLX) exposed to bidding volatility. The AVGO–MSFT custom-chip chatter increases Broadcom's pricing power in cloud ASICs; Marvell's forced selling signals a near-term supply of stock versus constrained buy-side demand for excluded names.

Tail risks concentrate around a fractured Fed: a three-way split or an unexpected no-cut/50bp move would spike 2yr yield vol and equity dispersion within 24–72 hours. Near-term (days) volatility is Fed-driven; short-term (weeks) is rebalancing and bid activity; long-term (quarters) depends on chip adoption, M&A approvals and labor-market durability. Hidden dependencies include contract timing between MSFT–AVGO, regulatory scrutiny on IBM–CFLT, and ETF flows into SP500 trackers after rebalances.

Trade implications: favour conviction-size, time-boxed directional and event trades — tactical long AVGO (2–3% net exposure, 2–8 weeks) versus short MRVL (1–2%, 2–6 weeks) to capture mechanical rebalancing and deal speculation. Implement merger-arb sized exposure to CFLT (long at discount to announced ~ $11bn consideration, hedge with small IBM short) and add rate-protection: buy 10–30 day interest-rate long-duration (TLT or 10y futures) conditional on a confirmed 25bp cut.

Contrarian angles: consensus 25bp cut is priced — markets underprice the probability of a split/no-cut outcome; if Powell flags uncertainty or labor-market resilience, tech multiple compression of 5–8% is plausible in 3–5 sessions. M&A euphoria can be overdone; treat CFLT as arbitrage, not momentum, and avoid owning marginally excluded names (MRVL) past 6–8 weeks without fundamental evidence of recovery.

Key Decisions for Investors

• Establish a 2–3% long position in AVGO (Broadcom) sized to portfolio risk for a 2–8 week horizon to capture upside from MSFT custom-chip talks; reduce if deal flow proves false or shares rally >10% from current levels.
• Enter a 1–2% short position in MRVL for 2–6 weeks to exploit S&P exclusion-driven outflows and ETF selling; cover or reassess if price retraces >15% from entry or if re-inclusion news emerges.
• Deploy a merger-arb position: size a long CFLT up to 1–3% notional if it trades below announced deal value (~$11bn consideration) and hedge with a proportionate short in IBM (net-neutral delta) until regulatory clearances (monitor for 90–180 day close window).
• Buy 10–30 day long-duration interest-rate protection (TLT or 10y futures) at 0.5–1% notional to benefit from a confirmed 25bp Fed cut; if 2yr yield drops >15bp intraday post-Powell, scale to full target size.
• Purchase 7–14 day ATM SPX straddle sized to 0.5–1% notional ahead of Powell to hedge Fed press-conference gamma risk; exit immediately after press conference or if implied vol contracts >25% from peak.